1. Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Issue 10322 (22nd January 2022) Authors: Jones, Stacie M; Kim, Edwin H; Nadeau, Kari C; Nowak-Wegrzyn, Anna; Wood, Robert A; Sampson, Hugh A; Scurlock, Amy M; Chinthrajah, Sharon; Wang, Julie; Pesek, Robert D; Sindher, Sayantani B; Kulis, Mike; Johnson, Jacqueline; Spain, Katharine; Babineau, Denise C; Chin, Hyunsook; Laurienzo-Panza, J... Journal: Lancet Issue: Volume 399:Issue 10322(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗